News

  • ACLA Applauds CMS’ Decision on Medicare Payment for Molecular Diagnostic Laboratory Tests; Has Serious Concerns About Drastic Cuts to Pathology Services

    November 02, 2012
    November 2, 2012 For Immediate Release Contact: Alan Mertz, 202-637-9466 ACLA Applauds CMS’ Decision on Medicare Payment for Molecular Diagnostic Laboratory Tests; Has Serious Concerns About Drastic Cuts to Pathology Services Washington, DC. The American Clinical Laboratory Association (ACLA) applauds the release yesterday of a final decision by the Centers for Medicare and Medicaid Services (CMS) regarding Medicare payment for molecular diagnostic tests performedContinue Reading »...
  • Controlling Chronic Kidney Disease Saves Lives and Money

    October 11, 2012
    Contact: Scott McGoohan American Clinical Laboratory Association Tel: 202.637.9466 Oct. 11, 2012 Controlling Chronic Kidney Disease Saves Lives and Money Low-Cost Lab Tests Help Slow a Disease Costing $60 Billion Annually WASHINGTON – There’s little debate about one health care issue: Taking steps to control chronic kidney disease will save lives and money. That’s especially true if you have diabetes or high blood pressure,Continue Reading »...
  • Comments Regarding CMS Proposed Payment Determinations for CLFS 2013

    September 28, 2012
        September 28, 2012   Mr. Glenn McGuirk Centers for Medicare & Medicaid Services Center for Medicare 7500 Security Boulevard Mail Stop C4-01-26 Baltimore, Maryland 21244   Dear Mr. McGuirk:   The American Clinical Laboratory Association (“ACLA”) is pleased to offer its comments on the Centers for Medicare and Medicaid Services’ (“CMS’s” or “the agency’s”) preliminary payment decisions for new and reconsidered ClinicalContinue Reading »...
  • ACLA Applauds House Passage of Bill that Increases Flexibility of Regulations which Threaten Access to Clinical Lab Tests

    September 20, 2012
    For Release: Sept. 20, 2012 Contact: Jason DuBois, 202-637-9466 ACLA Applauds House Passage of Bill that Increases Flexibility of Regulations which Threaten Access to Clinical Lab Tests WASHINGTON, DC—The American Clinical Laboratory Association (ACLA) today applauded the U.S. House of Representatives for yesterday’s passage of H.R. 6118, the Taking Essential Steps for Testing Act (TEST Act), introduced by Rep. Michael Grimm (R-NY). A SenateContinue Reading »...
  • Comments on PFS Proposed Rule for CY 2013

    September 04, 2012
        September 4, 2012   Ms. Marilyn Tavenner, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, S.W. Washington, DC 20201   RE: CMS-1590-P; Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule for CY 2013 – Proposed Rule   Dear Ms. Tavenner:   The American ClinicalContinue Reading »...
  • Comments Regarding ONC Lab Health IT Survey

    August 17, 2012
        August 17, 2012   COMMENTS OF THE AMERICAN CLINICAL LABORATORY ASSOCIATION ON OFFICE OF THE NATIONAL COORDINATOR FOR HEALTH INFORMATION TECHNOLOGY PROPOSED INFORMATION COLLECTION REQUEST REGARDING HEALTH INFORMATION EXCHANGE IN CLINICAL LABORATORIES   The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to offer its comments on the Office of the National Coordinator for Health Information Technology (“ONC”) proposed project, “National Survey on Health InformationContinue Reading »...
  • Letter to CMS Regarding POS Policy

    July 24, 2012
      July 24, 2012   Mr. Marc Hartstein Acting Director, Hospital and Ambulatory Policy Group Centers for Medicare & Medicaid Services Center for Medicare 7500 Security Boulevard Mail Stop C4-01-26 Baltimore, Maryland 21244   Dear Mr. Hartstein, The American Clinical Laboratory Association (ACLA) is writing to thank you and your colleagues for the time you took in March to discuss ACLA’s concerns about TransmittalContinue Reading »...
  • AIM Letter to Governor Cuomo Regarding NY Self Referral Bill

    July 20, 2012
      July 20, 2012 The Honorable Andrew M. Cuomo Governor of New York State NYS State Capitol Building Albany, NY 12224 RE: Assembly Bill 3551-A/Senate Bill 4660 Dear Governor Cuomo: The Alliance for Integrity in Medicare (AIM), a coalition of organizations committed to ending inappropriate physician self-referral, respectfully requests your veto of AB3551-A/SB4660. This legislation would undermine the New York State Public Health LawContinue Reading »...
  • Letter to Sen. Klobuchar Regarding TEST Act

    July 18, 2012
      July 18, 2012   The Honorable Amy Klobuchar United States Senate 302 Senate Hart Office Building Washington, DC 20510   Dear Senators Klobuchar:   The American Clinical Laboratory Association (ACLA) is pleased to offer our full and strong support for S. 3391, the Taking Essential Steps for Testing Act or TEST Act. This Bill would make a needed change to existing regulation benefittingContinue Reading »...
  • ACLA Applauds Introduction of Bill Increasing Flexibility of Regulations that Currently Limit Access to Clinical Laboratory Tests

    July 13, 2012
    Washington, DC—The American Clinical Laboratory Association (ACLA) today announced its “full and strong support” for H.R. 6118, the Taking Essential Steps for Testing Act or TEST Act introduced by Rep. Michael Grimm (R-NY) in the House of Representatives. The proposed legislation would address a lack of regulatory flexibility in the Clinical Laboratory Improvement Amendments (CLIA). The bill would grant the Centers for Medicare andContinue Reading »...